James Graham: CEO of Recce Pharmaceuticals
James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to address the threat of antibiotic-resistant superbugs.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.